Free Trial
NASDAQ:AVR

Anteris Technologies Global (AVR) Stock Price, News & Analysis

Anteris Technologies Global logo
$4.01 -0.37 (-8.45%)
As of 04:00 PM Eastern

About Anteris Technologies Global Stock (NASDAQ:AVR)

Key Stats

Today's Range
$3.98
$4.72
50-Day Range
$2.47
$5.51
52-Week Range
$2.34
$8.79
Volume
254,005 shs
Average Volume
204,561 shs
Market Capitalization
$144.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Buy

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Receive AVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anteris Technologies Global and its competitors with MarketBeat's FREE daily newsletter.

AVR Stock News Headlines

AVR Anteris Technologies Global Corp.
Another market crash is coming - here's when
Magnificent 7 Wipeout: What's Next? The first quarter stock crash and quick recovery has many people confused. And the coming months are critical. You need a big-picture plan... and you need to take specific actions starting TODAY. 50-year Wall Street veteran Marc Chaikin recently published his full big-picture plan, which lays out – based on more than 100 years of data – exactly what you can expect in the markets this year (and in 2026, too).
FY2026 Earnings Estimate for AVR Issued By Cantor Fitzgerald
See More Headlines

AVR Stock Analysis - Frequently Asked Questions

Anteris Technologies Global's stock was trading at $5.58 at the beginning of 2025. Since then, AVR shares have decreased by 28.1% and is now trading at $4.01.
View the best growth stocks for 2025 here
.

Anteris Technologies Global Corp (NASDAQ:AVR) released its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.61) earnings per share for the quarter.

Anteris Technologies Global (AVR) raised $89 million in an IPO on Friday, December 13th 2024. The company issued 14,800,000 shares at a price of $6.00 per share.

Anteris Technologies Global's lock-up period expired on Wednesday, June 11th. Anteris Technologies Global had issued 14,800,000 shares in its IPO on December 13th. The total size of the offering was $88,800,000 based on an initial share price of $6.00. Since the end of Anteris Technologies Global's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Anteris Technologies Global's top institutional investors include L1 Capital Pty Ltd (19.10%), ADAR1 Capital Management LLC (4.65%), Nantahala Capital Management LLC (4.61%) and Regal Partners Ltd (2.49%).

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/13/2025
Today
6/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:AVR
Previous Symbol
NASDAQ:AVR
Web
N/A
Fax
N/A
Employees
138
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.50
High Stock Price Target
$22.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+311.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.70 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$144.61 million
Optionable
N/A
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:AVR) was last updated on 6/16/2025 by MarketBeat.com Staff
From Our Partners